Neil Doctor
Interventional Pain Medicine · Midland, TXNPI 1619322492
Payments from drug & device makers
Across 83 payments — averaging $215.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Boston Scientific$380
- Globus Medical$301
- Revance Therapeutics, Inc.$138
- Abbott$121
- Nevro Corp.$106
- plus $408 from 8 others
What the payments were for
- Grants$15,00084%
- Travel & lodging$280%
- Food & beverage$2,82516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $16,400 |
| Boston Scientific | 5 | $380 |
| Globus Medical | 3 | $301 |
| Revance Therapeutics, Inc. | 1 | $138 |
| Abbott | 5 | $121 |
| Nevro Corp. | 1 | $106 |
| Merck | 1 | $100 |
| AbbVie | 1 | $89 |
| Si-bone, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $55 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
| Athena Bioscience, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$15,000
- Senza$378
- INTELLIS ADAPTIVESTIM$175
- INTELLIS$155
- SUPERION$139
- DAXXIFY$138
- OSTEOCOOL RF ABLATION$111
- BRIDION$100
How this compares
$17,853 in reported general payments places this provider in the 75th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 289 | $9,784 |
| Fentanyl | 23 | $2,384 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 43 | $842 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $841 |
| Gabapentin | 64 | $838 |
| Oxycodone Hcl | 60 | $832 |
| Cyclobenzaprine Hcl | 31 | $779 |
| Methocarbamol | 48 | $665 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $293 |
| Pregabalin | 17 | $293 |
| Meloxicam | 65 | $219 |
| Tizanidine Hcl | 23 | $208 |
| Tramadol Hcl | 26 | $180 |
| Baclofen | 21 | $175 |
| Topiramate | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Midland
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
- Ankur KhoslaShenandoah$511K
- Brian RichDecatur$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.